ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Endometrial Cancer

Prostate Cancer trials near San Diego, CA, USA:

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (CANOPY)

single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate...

Enrolling
Metastatic Cancer
Castration-resistant Prostate Cancer
Drug: Cabozantinib
Drug: Nivolumab

Phase 2

Rana McKay, MD

La Jolla, California, United States and 3 other locations

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate...

Enrolling
Benign Prostatic Hyperplasia
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

La Mesa, California, United States and 5 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Not yet enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

La Jolla, California, United States and 113 other locations

This is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate...

Enrolling
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer (Adenocarcinoma)
Drug: ACE-232 tablets

Phase 1

Acerand Therapeutics (Hong Kong) Limited

La Jolla, California, United States and 7 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

La Jolla, California, United States and 22 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

San Diego, California, United States and 131 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

La Jolla, California, United States and 31 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + carboplatin + cabazitaxel

Phase 2

Xencor
Xencor

San Diego, California, United States and 25 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Placebo
Drug: Prednisone

Phase 2, Phase 3

Lilly
Lilly

La Jolla, California, United States and 112 other locations

as a possible treatment for metastatic hormone-sensitive prostate cancer. The names of the study drugs involved in this study are:*...

Active, not recruiting
Metastasis Prostate Adenocarcinoma
Prostate Adenocarcinoma
Drug: Docetaxel
Drug: Nivolumab

Phase 2

Xiao X. Wei, MD

La Jolla, California, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems